Literature DB >> 32156643

The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation.

Jean-Jacques Rouby1, Antoine Monsel2, Marc Leone3, Olivier Mimoz4, Pierre-François Laterre5, Jérôme Pugin6.   

Abstract

Entities:  

Keywords:  Amikacin; Epithelial lining fluid; Multidrug-resistant Gam-negative bacteria; Nebulised antibiotics; Tobramycin; Ventilator-associated pneumonia

Mesh：

Substances：

Year:  2020        PMID： 32156643     DOI： 10.1016/j.accpm.2020.03.007

Source DB:  PubMed          Journal:  Anaesth Crit Care Pain Med        ISSN： 2352-5568            Impact factor:   4.132


× No keyword cloud information.
  3 in total

1.  Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists.

Authors:  Lijie Xu; Xuefang Cheng; Guanhua Zhu; Juanni Hu; Qin Li; Guorong Fan
Journal:  Eur J Hosp Pharm       Date:  2021-11-17

2.  Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta.

Authors:  Jean-Jacques Rouby; Yinggang Zhu; Antoni Torres; Jordi Rello; Antoine Monsel
Journal:  Ann Intensive Care       Date:  2022-10-17       Impact factor: 10.318

Review 3.  Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives.

Authors:  Yinggang Zhu; Antoine Monsel; Jason A Roberts; Konstantinos Pontikis; Olivier Mimoz; Jordi Rello; Jieming Qu; Jean-Jacques Rouby
Journal:  Microorganisms       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.